Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13416
Country/Region: Uganda
Year: 2015
Main Partner: Mildmay International
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $9,755,670 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,373,927
Care: Orphans and Vulnerable Children (HKID) $602,508
Care: TB/HIV (HVTB) $395,925
Care: Pediatric Care and Support (PDCS) $973,439
Laboratory Infrastructure (HLAB) $396,736
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $300,668
Sexual Prevention: Other Sexual Prevention (HVOP) $187,793
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $763,209
Treatment: Adult Treatment (HTXS) $2,512,999
Treatment: Pediatric Treatment (PDTX) $248,466
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 16,650
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 17,990
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,686
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,831
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 32,482
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 35,150
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,007
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,172
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 52,825
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 57,143
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 52,825
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 57,143
CARE_NEW Aggregated Age/sex: <15 Female 2016 514
CARE_NEW Aggregated Age/sex: <15 Male 2016 456
CARE_NEW Aggregated Age/sex: 15+ Female 2016 8,943
CARE_NEW Aggregated Age/sex: 15+ Male 2016 4,869
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 14,782
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 14,782
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 14,782
FN_THER Aggregated Age: <18 2016 527
FN_THER Aggregated Age: 18+ 2016 844
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 1,371
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 17,146
FN_THER Sum of Aggregated Age disaggregates 2016 1,371
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 17,222
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 18,842
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 14,206
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 12,989
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 131,516
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 143,864
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 94,775
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 103,674
HTS_TST By Test Result: Negative 2016 270,205
HTS_TST By Test Result: Negative 2016 246,914
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 280,586
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 256,502
HTS_TST Sum of Aggregated Age/Sex <15 2016 30,211
HTS_TST Sum of Aggregated Age/Sex <15 2016 33,048
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 226,291
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 247,538
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 256,502
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 280,586
HTS_TST Sum of Test Result disaggregates 2016 280,586
HTS_TST Sum of Test Result disaggregates 2016 256,502
HTS_TST_POS By Test Result: Positive 2016 10,381
HTS_TST_POS By Test Result: Positive 2016 9,588
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 9,241
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2016 9,900
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 77
LAB_CAP By clinical laboratories 2016 63
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 63
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 587
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 16,598
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 5,955
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 6,634
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 5,955
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 6,634
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 5,207
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 5,602
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 748
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 1,032
PMTCT_ARV Sum of New and Current disaggregates 2016 5,955
PMTCT_ARV Sum of New and Current disaggregates 2016 6,634
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 534
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 5,312
PMTCT_EID Sum of Infant Age disaggregates 2016 5,312
PMTCT_STAT By: Known positives at entry 2016 5,208
PMTCT_STAT By: Known positives at entry 2016 5,602
PMTCT_STAT By: Number of new positives identified 2016 747
PMTCT_STAT By: Number of new positives identified 2016 1,032
PMTCT_STAT Number of new ANC and L&D clients 2016 46,169
PMTCT_STAT Number of new ANC and L&D clients 2016 54,958
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 43,877
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 52,193
PMTCT_STAT Sum of Positives Status disaggregates 2016 5,955
PMTCT_STAT Sum of Positives Status disaggregates 2016 6,634
PP_PREV Age/sex: 10-14 Female 2016 13,086
PP_PREV Age/sex: 10-14 Female 2016 490
PP_PREV Age/sex: 10-14 Male 2016 9,968
PP_PREV Age/sex: 10-14 Male 2016 1,132
PP_PREV Age/sex: 15-19 Female 2016 23,151
PP_PREV Age/sex: 15-19 Female 2016 3,795
PP_PREV Age/sex: 15-19 Male 2016 18,027
PP_PREV Age/sex: 15-19 Male 2016 7,286
PP_PREV Age/sex: 20-24 Female 2016 34,210
PP_PREV Age/sex: 20-24 Female 2016 5,654
PP_PREV Age/sex: 20-24 Male 2016 19,548
PP_PREV Age/sex: 20-24 Male 2016 7,991
PP_PREV Age/sex: 25-49 Female 2016 49,429
PP_PREV Age/sex: 25-49 Female 2016 8,137
PP_PREV Age/sex: 25-49 Male 2016 34,740
PP_PREV Age/sex: 25-49 Male 2016 14,024
PP_PREV Age/sex: 50+ Female 2016 523
PP_PREV Age/sex: 50+ Male 2016 1,205
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 208,459
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 50,238
PP_PREV Sum of Age/Sex disaggregates 2016 208,459
PP_PREV Sum of Age/Sex disaggregates 2016 50,237
TB_ART Aggregated Age: <15 2016 64
TB_ART Aggregated Age: 15+ 2016 803
TB_ART Female 2016 555
TB_ART Male 2016 312
TB_ART Sum of Aggregated Age disaggregates 2016 867
TB_ART Sum of Sex disaggregates 2016 867
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 867
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 4,000
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 53,143
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 52,825
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 57,143
TB_SCREEN Sex: Female 2016 37,310
TB_SCREEN Sex: Male 2016 19,833
TB_SCREEN Sum of Aggregated Age disaggregates 2016 57,143
TB_SCREEN Sum of Sex disaggregates 2016 57,143
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 57,143
TX_CURR Aggregated Age/Sex: 15+ Female 2016 14,378
TX_CURR Aggregated Age/Sex: 15+ Female 2016 15,621
TX_CURR Aggregated Age/Sex: 15+ Male 2016 31,247
TX_CURR Aggregated Age/Sex: 15+ Male 2016 33,931
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 49,255
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 53,484
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 45,625
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 49,552
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 45,625
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 49,552
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 6,123
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 12,928
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 19,875
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 19,051
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 12,376
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 14,563